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Allele-Specific Targeting of microRNAs to HLA-G and Risk
of Asthma
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HLA-G is a nonclassic, class I HLA molecule that has important immunomodulatory properties. Previously, we identified
HLA-G as an asthma-susceptibility gene and discovered that the risk of asthma in a child was determined by both the
child’s HLA-G genotype and the mother’s affection status. Here we report a SNP in the 3′ untranslated region of HLA-G
that influences the targeting of three microRNAs (miRNAs) to this gene, and we suggest that allele-specific targeting of
these miRNAs accounts, at least in part, for our earlier observations on HLA-G and the risk of asthma.
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The class Ib HLA gene, HLA-G (MIM 142871), is primarily
expressed by fetal cells at the maternal-fetal interface,
where it displays immunosuppressive properties, and is
thought to contribute to the maternal tolerance of the
genetically foreign fetus.1 We previously identified HLA-
G as an asthma (MIM 600807) gene in a positional cloning
study in white Chicago families.2 In the Chicago families
and in a Dutch population, the risk genotype at HLA-G
varied depending on whether the mother had asthma or
bronchial hyperresponsiveness (BHR) or was unaffected.
For example, in both populations, the GG genotype at
SNP 964G/A in the promoter region of HLA-G was as-
sociated with asthma in children of affected mothers,
whereas the AA genotype was associated with asthma in
children of unaffected mothers. A similar interaction was
observed with 1489C/T, the SNP that explained nearly
the entire linkage signal in the Chicago families.2 We then
focused our studies on the highly polymorphic promoter
region and showed that the 964G/A SNP tagged two
major haplotype clades with evidence of longstanding bal-
ancing selection,3 but we could not demonstrate func-
tional differences between these two promoter clades by
use of luciferase reporter assays.4 Last, we showed expres-
sion of soluble (s)HLA-G protein in bronchial epithelial
cells in two individuals with asthma but not in one un-
affected control individual, suggesting that this gene was
up-regulated in the asthmatic lungs.2
Because of the strong linkage disequilibrium (LD) be-
tween SNPs in the HLA-G gene (fig. 1), we turned our
attention to other regions of the gene to identify variation
that contributes to asthma risk. As part of these studies,
we identified in the 3′ UTR of HLA-G a putative target site
for three microRNAs (miRNAs): miR-148a, miR-148b, and
miR-152. A C/G SNP at 3142 in the HLA-G mRNA is
located in the seed region of this target site.
miRNAs are a family of endogenous, small, noncoding
RNAs, ∼22 nt in length, that negatively regulate gene ex-
pression by suppressing translation or degrading mRNA.5
They have important and diversified functions—including
development and differentiation,6 apoptosis,7 hemato-
poiesis,8 and tumorigenesis,9 as well as insulin secretion10
and viral defense11—and have been shown to be involved
in various human diseases, including cancer12 and fragile
X syndrome.13 Although polymorphisms in miRNA genes
may be scarce,14 polymorphisms in miRNA target sites are
abundant. Some of these polymorphisms influence the
binding of miRNAs and have been associated with mus-
cularity in sheep and with Tourette syndrome.15,16 Here we
demonstrate that 3142C/G influences miRNA targeting
of HLA-G and is associated with risk of asthma.
For miRNA target site predictions in HLA-G, we used
MicroInspector,17 TargetScan,18 DIANA-microT,19 Mi-
Randa,6 and PicTar,20 as well as our own algorithm, which
is based on the criteria of Watson-Crick base-pair of the
5′ “2–8” nucleotides of miRNA to target sequence and
more stable binding of miRNA to the target region than
to the flanking region. On the basis of the results of those
prediction programs, we selected three target sites for fur-
ther study: target for miR-148a/148b/152, target for miR-
143, and target for miR-524*. We used RNAhybrid21 to
analyze the targeting of miR-148a, miR-148b, and miR-152
to HLA-G. On the basis of the calculation of minimum
free energy (MFE), the binding of miRNA to the 3142G
allele is predicted to be more stable than binding to the
3142C allele (fig. 2). Thus, 3142 might influence the
binding of miRNA to HLA-G, and therefore HLA-G protein
expression, in an allele-specific manner. To test this hy-
pothesis, we performed luciferase assays. We used firefly
luciferase plasmid pLS-HX, which was constructed by in-
serting firefly luciferase ORF between SacI and XbaI of pCL-
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Figure 1. Pairwise linkage disequilibrium ( ) map of HLA-G in2r
the Chicago families. The LD plot was made by LDPlotter.
Figure 2. Predicted binding of miR-148a, miR-148b, and miR-
152 to HLA-G. The seed region of the target site is shown in bold
letters, and 3142C/G is indicated by an arrow. The minimum free
energy (MFE) of the RNA duplex was analyzed by RNAhybrid.
con,22 and renilla plasmid pRL, which was constructed by
inserting renilla luciferase between SacI and EcoRI of pCL-
con. A 365-bp region of HLA-G 3′ UTR, containing the
insertion allele at the exon 8 insertion/deletion (indel),23
was amplified using forward (CTAGAAGCTTTGTGAAAC-
AGCTGCCC) and reverse (CGCTAGTCTAGATGTCTCTC-
AAATTTC) primers, was digested with HindIII and XbaI,
and was ligated into pLS-HX. Site-directed mutagenesis
was performed using QuikChange II XL kit (Stratagene)
to generate pluc-HLAG-G and pluc-HLAG-C that carry ei-
ther C or G at HLA-G 3142, and pluc-HLA-G-Del, which
has the miRNA target site (22 bp) deleted. We then co-
transfected pluc-HLAG-G, pluc-HLAG-C, or pluc-HLA-Del
and pRL with either miR-148a, miR-148b, miR-152, or a
negative control miRNA (NC miRNA) (Dharmacon) into
a human bronchial epithelial cell line, 16HBE14o-.24 For
each well, 50 ng luciferase plasmid, 2 ng renilla plasmid,
and 20 nM (final concentration) miRNA were transfected
using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s protocol. Cells were lysed 40 h after trans-
fection, and luciferase and renilla activities were deter-
mined by use of Dual-Luciferase Reporter kit (Promega)
and Veritas Microplate Luminometer (Turner Biosystems).
We found that, although normalized luciferase activity of
either plasmid was not significantly different when cells
were cotransfected with NC miRNA, the activity of pluc-
HLAG-G in the presence of each of the three miRNAs was
significantly lower than those of pluc-HLAG-C and pluc-
HLA-G-Del. This indicates allele-specific targeting of the
three miRNAs to HLA-G (fig. 3a). We were not able to
confirm the target for miR-143 or the one for miR-524* by
luciferase experimentation.
To validate the presence of the miRNA target site in the
endogenous HLA-G gene, we used a choriocarcinoma cell
line JEG3 (ATCC), which constitutively expresses high lev-
els of HLA-G and has the GG genotype at 3142. We
transfected JEG3 cells with miR-148a, NC miRNA, or HLA-
G small interfering RNA (siRNA) (positive control), and we
measured soluble HLA-G level in cell supernatants 5 d after
transfection by use of an HLA-G ELISA kit (Biovendor &
Exbio). sHLA-G levels were significantly decreased by miR-
148a and by HLA-G siRNA, compared with the NC miRNA
( and , respectively), confirming thePp .019 Pp .0048
presence of a functional target site on the 3142G allele
(fig. 3b). Next, we measured expression of the three
miRNAs by real-time PCR in mRNA from primary cyto-
trophoblast (CTB) cells, which have high constitutive ex-
pression of HLA-G, and in primary bronchial epithelial
cells,25 which have low constitutive expression of HLA-G.
miRNA was extracted by mirVana miRNA isolation kit
(Ambion), and miRNA real-time PCR was performed with
20 ng miRNA and mirVana miRNA detection kit and
www.ajhg.org The American Journal of Human Genetics Volume 81 October 2007 831
Figure 3. HLA-G 3142C/G affects the targeting of miR-148a, miR-148b, and miR-152 to HLA-G and interacts with mother’s asthma
status to determine risk of asthma in the child. a, Luciferase assays showing the allele-specific targeting of the three miRNAs to HLA-
G in 16HBE14o- cells. pluc-HLAG-G (G), pluc-HLAG-C (C), or pluc-HLA-G-Del (Del) luciferase plasmid was cotransfected with negative
control miRNA, miR-148a, miR-148b, or miR-152. At least six replicate assays were performed for each transfection. For each sample,
luciferase activity was normalized by renilla activity and then normalized again by the median value of the pluc-HLAG-C plasmid within
each miRNA transfection group. The P values for the difference in luciferase activity of the three plasmids are as follows. For NC miRNA
transfection: G versus C, ; G versus Del, . For miR-148a transfection: G versus C, ; G versus Del, . ForP 1 .05 P 1 .05 Pp .0002 P ! .0001
miR-148b transfection: G versus C, ; G versus Del, . For miR-152 transfection: G versus C, ; G versus Del,P ! .0001 P ! .0001 Pp .0002
. b, Endogenous HLA-G expression is inhibited by miR-148a in JEG3 cells. JEG3 cells, which are 3142GG, were transfectedPp .0016
with either negative control miRNA, miR-148a, or HLA-G siRNA as a positive control. A total of seven replicate assays were performed
for each RNA. miR-148a and HLA-G siRNA significantly reduced the level of sHLA-G in JEG3 supernatant compared with the NC miRNA.
sHLA-G level was normalized to the median of the HLA-G siRNA group. c, miR-148a and miR-148b levels in primary cytotrophoblast
(CTB) cells from six individuals and primary bronchial epithelial (BE) cells from three individuals, determined by miRNA real-time PCR.
miR-148a ( ) and miR-148b ( ) levels were significantly lower in CTB cells than in BE cells. d, 3142C/G interactsPp .0016 Pp .0006
with maternal asthma status and is associated with asthma in the COAST children. Dashed lines are the children of mothers with asthma
( ), and solid lines are the children of mothers without asthma ( ). The interaction .Np 58 Np 119 Pp .0011
primer sets (Ambion). For normalization, U6 real-time PCR
was also performed for these samples, and comparative
method was used to calculate the relative abundanceCt
of the miRNAs in these samples. The expression of miR-
148a and miR-148b, but not of miR-152, was detected in
bronchial epithelial cells and to a lesser extent in CTB cells
(fig. 3c). The higher expression of the miRNAs in bronchial
epithelial cells compared with cytotrophoblast cells is con-
sistent with the inverse expression pattern of HLA-G,
which is low in the former and high in the latter cells
(unpublished data).
HLA-G 3142C/G is in high LD with the HLA-G pro-
moter polymorphism that was associated with asthma in
the Chicago and Dutch families (fig. 1). Thus, it is possible
that 3142C/G could account for at least some of the
previously observed association. To further explore this
possibility, we studied a third population consisting of
children participating in Childhood Origins of ASThma
(COAST), a birth cohort study. Couples in which at least
one parent had asthma or allergies were recruited into the
COAST study in Madison, WI, during pregnancy.26 Their
children are at high risk for developing asthma and have
been followed from birth through age 6 years, at which
time asthma was diagnosed. We genotyped 180 white
COAST children for four polymorphisms in HLA-G:
1306G/A, which is in perfect LD with the promoter SNP
(964G/A) that was associated with asthma in the Chi-
cago and Dutch families2 (fig. 1); 1489C/T, a synony-
mous SNP in exon 3 that explained most of the evidence
for linkage in the Chicago families2; a 14-bp indel in
the 3′ UTR that has been associated with mRNA stability,23
and 3142C/G. We tested for interaction effects between
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Table 1. Interaction of HLA-G Genotypes and Maternal Asthma Status on
Asthma Risk in COAST Children
SNP and Genotype
No. of Children, by Affection Status
Pinteraction
Mothers
Affected
Mothers
Unaffected
Children
Affected
Children
Unaffected
Children
Affected
Children
Unaffected
HLA-G 1306 (rs1736936): .0045
GG 6 10 14 35
AG 14 15 11 43
AA 0 11 5 9
HLA-G 1489 (rs1130356): .0978
CC 9 16 18 44
CT 10 12 9 28
TT 0 3 4 4
HLA-G exon 8 indel (rs16375): .0142
DelDel 6 15 14 38
InsDel 14 14 14 44
InsIns 0 9 4 8
HLA-G 3142 (rs1063320): .0011
CC 3 8 10 29
CG 17 18 15 48
GG 0 12 7 10
NOTE.—The minor-allele frequencies at each polymorphism in the COAST children are 0.395
(1306A), 0.293 (1489T), 0.372 (exon 8 ins), and 0.461 (3142G).
mother’s affection status (asthma vs. no asthma) and the
child’s genotype on the development of asthma by age 6
years in this cohort by logistic regression, as described
elsewhere.26 To assess the significance of this interaction,
children’s asthma status was permuted 10,000 times,
whereas mothers’ status and children’s genotypes were
unchanged. For each generated data set, a log likelihood–
ratio test was performed to compare the model with in-
teraction to the one without interaction. Permuted P val-
ues (Pinteraction) were determined by the number of data sets
that had smaller log likelihood P values than the original
data set. Significant interactions ( ) were observed atP ! .01
all SNPs tested except the exon 3 synonymous 1489C/
T SNP (table 1); however, the association with 3142C/
G was the most significant (permutation P pinteraction
). In the COAST cohort, the GG genotype is pro-0.0011
tective against asthma among children of asthmatic moth-
ers (0 of 20 asthmatic children were GG; ,Pp .0036
Fisher’s exact test) but is associated with modest risk of
asthma among children of nonasthmatic mothers (7 of
32 asthmatic children were GG; , Fisher’s exactPp .39
test) (fig. 3d and table 1). Thus, consistent with our earlier
report in two other white populations, the3142G allele,
or promoter alleles in strong LD with 3142G ( 2r p
between 3142 and either 964 or 1306), is a sus-0.76
ceptibility allele among children of asthmatic mothers,
and the C allele may be a risk allele (albeit more modest)
among children of nonasthmatic mothers. Interestingly,
the three miRNA genes are located at regions that have
been linked to asthma or IgE: 7p15 (miR-148a), 12q13
(miR-148b), and 17q21 (miR-152),27,28 raising the possibil-
ity that variation in the miRNA genes themselves might
contribute to asthma risk, perhaps by interacting with
HLA-G.
It has become evident in recent years that gene-envi-
ronment interactions play an important role in the eti-
ology of common diseases,29,30 and it has even been sug-
gested that genes with main effects on disease risk are
more the exception than the rule.31 Identification and
characterization of such interactions is critical for both
basic research and clinical practice by helping to explain
some of the inconsistencies of disease-association studies
and by identifying individuals with genotype-specific risks
for detrimental environmental exposures. Here we ob-
served that a functional polymorphism in HLA-G interacts
with mother’s asthma status, which represents an “in
utero” environmental exposure. This interaction has now
been observed in three white populations ascertained us-
ing three different study designs: families ascertained
through affected sib pairs in the Chicago study,2 families
ascertained through an affected parent originally studied
20 years earlier in the Dutch study,32 and children partic-
ipating in a birth cohort study.26 Thus, the finding of an
interaction between maternal affection status and child’s
HLA-G genotype seems robust to study design and is par-
ticularly intriguing for two reasons. First, maternal asthma
remains the most significant and best replicated risk factor
for asthma in children,26,33 and, second, HLA-G is most
highly expressed during pregnancy, when it is thought to
play a key role in modulating immune tolerance toward
the genetically foreign fetus by enhancing the Th2 arm
of the immune system.1 Asthma and allergic disease are
also characterized by a skewing toward Th2 immunity.
Our study suggests that maternal asthma influences chil-
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dren’s risk in an allele-specific manner and that the im-
munosuppressive (Th2-skewing) properties of HLA-G pro-
mote asthma pathogenesis.
Although the mechanism of this interaction is still un-
known, the results of this study suggest that fetal miRNA
regulation might differ in pregnancies of asthmatic and
nonasthmatic mothers. The fetal lung is bathed in am-
niotic fluid that is swallowed by the fetus, and this could
provide a direct route for maternal factors to modulate
fetal gene expression in the lung as an epigenetic phe-
nomenon. Regardless of mechanism, however, the dis-
covery that a 3′ UTR polymorphism affects miRNA tar-
geting reveals a novel functional mechanism by which
noncoding polymorphisms can contribute to the risk of
common disease. Because ∼30% of human genes are reg-
ulated by miRNAs,18 the involvement of miRNA regulation
in human diseases may be quite prevalent. This might be
particularly relevant to common diseases, to which many
susceptibility loci with small effects on gene expression
likely contribute. Our study suggests that allele-specific
miRNA targeting may indeed be a common mechanism
of human disease pathogenesis.
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